Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.635 USD | +4.16% |
|
+19.06% | +230.27% |
Jul. 01 | Summit Therapeutics Inc.(NasdaqGM:SMMT) added to Russell Small Cap Comp Value Index | CI |
Jul. 01 | Summit Therapeutics Inc.(NasdaqGM:SMMT) dropped from Russell Microcap Growth Index | CI |
Chart calendar Summit Therapeutics Inc.
Upcoming events on Summit Therapeutics Inc.
Past events on Summit Therapeutics Inc.
2024-06-14 09:00 am | Annual General Meeting |
2024-06-03 08:00 am | Business Update Call |
2024-05-01 09:00 am | Q1 2024 Earnings Call |
2024-05-01 07:00 am | Q1 2024 Earnings Release |
2024-04-16 02:30 pm | Stifel Virtual Targeted Oncology Days Conference - Fireside Chat |
2024-03-22 07:00 am | European Lung Cancer Congress - Presentation No 174P |
2024-03-22 07:00 am | European Lung Cancer Congress - Presentation No 68P |
2024-03-12 02:35 pm | Barclays Global Healthcare Conference |
2024-02-20 09:00 am | Q4 2023 Earnings Call |
2024-02-20 07:00 am | Q4 2023 Earnings Release |
2024-02-14 02:40 pm | Oppenheimer Healthcare Life Sciences Conference |
2024-01-09 04:30 pm | JPMorgan Healthcare Conference |
2023-11-07 09:00 am | Q3 2023 Earnings Call |
2023-11-07 07:00 am | Q3 2023 Earnings Release |
2023-11-04 02:55 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number.: 1194 |
2023-10-11 | Extraordinary Shareholders Meeting |
2023-08-09 09:00 am | Q2 2023 Earnings Call |
2023-08-09 07:00 am | Q2 2023 Earnings Release |
2023-06-04 09:00 am | American Society of Clinical Oncology Meeting - Abstract No 9087 |
2023-05-23 01:00 pm | Annual General Meeting |
Annual results
Fiscal Period | December | 2019 | 2020 | 2023 | 2024 |
---|---|---|---|---|---|
Net sales Million GBP | Released Forecast Spread | 15,7 15,7 0.1% | 14,5 15,2 -4.37% | 0,00 | 0,00 |
EBITDA Million GBP | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 | -138 |
EBIT Million GBP | Released Forecast Spread | -25,3 -23,4 -8.21% | -38,3 -43,3 11.45% | 0,00 | -142 |
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | -25,6 -21,6 -18.42% | 0,00 0,00 - | 0,00 | 0,00 |
Net income Million GBP | Released Forecast Spread | -22,0 -18,5 -18.95% | 0,00 0,00 - | -486 | 0,00 |
EPS GBP | Released Forecast Spread | -0,13 -0,12 -13.04% | 0,00 0,00 - | -0,78 | 0,00 |
Announcement Date | 30/04/20 | 17/03/21 | 20/02/24 | - |
Quarterly results
Fiscal Period | December | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|
Net sales Million GBP | Released Forecast Spread | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
EBITDA Million GBP | Released Forecast Spread | -35,1 | -34,7 | -34,3 | |||
EBIT Million GBP | Released Forecast Spread | -33,9 -31,6 -7% | -35,6 | -36,5 | -36,7 | -40,7 | -43,0 |
Announcement Date | 01/05/24 | - | - | - | - | - |
Past sector events for Summit Therapeutics Inc.
2024-07-04 | PHARMAESSENTIA CORPORATION: June 2024 Sales and Revenue Release |
2024-06-05 03:51 am | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SMMT Stock
- Calendar Summit Therapeutics Inc.